Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Kozono

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Medrxiv : the Preprint Server for Health Sciences|January 20, 2025
Metastatic spine disease alters spinal load-to-strength ratios in patients compared to healthy individualsDennis E Anderson, Mario Keko, Joanna James, et al.
JCO Precision Oncology|February 9, 2022
Outcomes by <i>EGFR</i>, <i>KRAS</i>, and <i>ALK</i> Genotype After Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung CancerRaymond H Mak, Gretchen Hermann, Hugo J Aerts, et al.
Radiation Oncology (London, England)|January 16, 2020
The impact of quantitative CT-based tumor volumetric features on the outcomes of patients with limited stage small cell lung cancerSophia C Kamran, Thibaud Coroller, Nastaran Milani, et al.
Molecular Cell|December 22, 2018
USP1 Is Required for Replication Fork Protection in BRCA1-Deficient TumorsKah Suan Lim, Heng Li, Emma A Roberts, et al.
JTO Clinical and Research Reports|September 30, 2021
Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastatic NSCLCThomas A Hensing, Xiaofei Wang, Thomas E Stinchcombe, et al.
Plos One|April 21, 2017
Lymph node volume predicts survival but not nodal clearance in Stage IIIA-IIIB NSCLCVishesh Agrawal, Thibaud P Coroller, Ying Hou, et al.
Journal of Geriatric Oncology|August 6, 2025
Geriatric assessment among vulnerable older adults undergoing stereotactic body radiotherapy for early-stage non-small cell lung cancerLeah L Thompson, Sarah M Lipson, Jaewon Yoon, et al.
JOR Spine|January 8, 2026
Metastatic Spine Disease Alters Vertebral Load-To-Strength Ratios in Cancer Patients Compared to Healthy IndividualsDennis E Anderson, Mario Keko, Joanna James, et al.
Clinical Lung Cancer|May 25, 2022
Alliance A082002 -a randomized phase II/III trial of modern immunotherapy-based systemic therapy with or without SBRT for PD-L1-negative, advanced non-small cell lung cancerSteven E Schild, Xiaofei Wang, Christine M Bestvina, et al.
Oncotarget|March 25, 2014
Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastomaJie Li, Shan Zhu, David Kozono, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Medrxiv : the Preprint Server for Health Sciences|January 20, 2025
Metastatic spine disease alters spinal load-to-strength ratios in patients compared to healthy individualsDennis E Anderson, Mario Keko, Joanna James, et al.
JCO Precision Oncology|February 9, 2022
Outcomes by <i>EGFR</i>, <i>KRAS</i>, and <i>ALK</i> Genotype After Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung CancerRaymond H Mak, Gretchen Hermann, Hugo J Aerts, et al.
Radiation Oncology (London, England)|January 16, 2020
The impact of quantitative CT-based tumor volumetric features on the outcomes of patients with limited stage small cell lung cancerSophia C Kamran, Thibaud Coroller, Nastaran Milani, et al.
Molecular Cell|December 22, 2018
USP1 Is Required for Replication Fork Protection in BRCA1-Deficient TumorsKah Suan Lim, Heng Li, Emma A Roberts, et al.
JTO Clinical and Research Reports|September 30, 2021
Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastatic NSCLCThomas A Hensing, Xiaofei Wang, Thomas E Stinchcombe, et al.
Plos One|April 21, 2017
Lymph node volume predicts survival but not nodal clearance in Stage IIIA-IIIB NSCLCVishesh Agrawal, Thibaud P Coroller, Ying Hou, et al.
Journal of Geriatric Oncology|August 6, 2025
Geriatric assessment among vulnerable older adults undergoing stereotactic body radiotherapy for early-stage non-small cell lung cancerLeah L Thompson, Sarah M Lipson, Jaewon Yoon, et al.
JOR Spine|January 8, 2026
Metastatic Spine Disease Alters Vertebral Load-To-Strength Ratios in Cancer Patients Compared to Healthy IndividualsDennis E Anderson, Mario Keko, Joanna James, et al.
Clinical Lung Cancer|May 25, 2022
Alliance A082002 -a randomized phase II/III trial of modern immunotherapy-based systemic therapy with or without SBRT for PD-L1-negative, advanced non-small cell lung cancerSteven E Schild, Xiaofei Wang, Christine M Bestvina, et al.
Oncotarget|March 25, 2014
Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastomaJie Li, Shan Zhu, David Kozono, et al.
Pageof 8